Akamai Technologies, Inc. (AKAM) Stock Forecast
Data as of May 2, 2026Technology · Current price $104.08 (+1.12%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 12, 2026 | Frank Louthan | Raymond James | $120.00 | +15.3% |
| Feb 23, 2026 | Frank Louthan | Raymond James | $100.00 | -3.9% |
| Feb 20, 2026 | Patrick Colville | Scotiabank | $120.00 | +15.3% |
| Feb 20, 2026 | Roger Boyd | UBS | $110.00 | +5.7% |
| Feb 20, 2026 | Sanjit Singh | Morgan Stanley | $120.00 | +15.3% |
| Jan 5, 2026 | James Fish | Piper Sandler | $89.00 | -14.5% |
| Dec 15, 2025 | Jackson Ader | KeyBanc | $115.00 | +10.5% |
| Aug 8, 2025 | James Fish | Piper Sandler | $83.00 | -20.3% |
| Apr 16, 2025 | Keith Weiss | Morgan Stanley | $90.00 | -13.5% |
| Nov 11, 2024 | William Power | Robert W. Baird | $115.00 | +10.5% |
| Nov 11, 2024 | Stephen Bersey | HSBC | $121.00 | +16.3% |
| Aug 9, 2024 | Jeff Van Rhee | Craig-Hallum | $125.00 | +20.1% |
| Aug 9, 2024 | Patrick Colville | Scotiabank | $115.00 | +10.5% |
| Aug 9, 2024 | Mark Mahaney | RBC Capital | $100.00 | -3.9% |
| Jul 29, 2024 | Raymond McDonough | Guggenheim | $128.00 | +23.0% |
| Jul 24, 2024 | Stephen Bersey | HSBC | $96.00 | -7.8% |
| Jul 15, 2024 | James Fish | Piper Sandler | $112.00 | +7.6% |
| Jul 8, 2024 | Patrick Colville | Scotiabank | $110.00 | +5.7% |
| May 10, 2024 | Shyam Patil | Susquehanna | $135.00 | +29.7% |
| May 10, 2024 | James Fish | Piper Sandler | $114.00 | +9.5% |
Top Analysts Covering AKAM
AKAM vs Sector & Market
| Metric | AKAM | Technology Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.52 | 2.34 | 2.41 |
| Analyst Count | 23 | 13 | 18 |
| Target Upside | +6.8% | +4072.7% | +14.9% |
| P/E Ratio | 33.79 | 27.89 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $4.47B | $4.48B | $4.51B | 18 |
| 2027-03-31 | $1.13B | $1.14B | $1.15B | 6 |
| 2027-06-30 | $1.16B | $1.17B | $1.18B | 6 |
| 2027-09-30 | $1.18B | $1.20B | $1.21B | 6 |
| 2027-12-31 | $1.24B | $1.25B | $1.26B | 6 |
| 2028-03-31 | $1.21B | $1.23B | $1.23B | 5 |
| 2028-06-30 | $1.23B | $1.24B | $1.25B | 5 |
| 2028-09-30 | $1.26B | $1.28B | $1.28B | 6 |
| 2028-12-31 | $1.33B | $1.35B | $1.36B | 8 |
| 2029-12-31 | $5.49B | $5.60B | $5.73B | 5 |
| 2030-12-31 | $6.25B | $6.37B | $6.53B | 5 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $6.65 | $6.85 | $7.01 | 15 |
| 2027-03-31 | $1.73 | $1.76 | $1.77 | 5 |
| 2027-06-30 | $1.80 | $1.83 | $1.84 | 5 |
| 2027-09-30 | $1.89 | $1.92 | $1.93 | 5 |
| 2027-12-31 | $2.00 | $2.04 | $2.05 | 5 |
| 2028-03-31 | $1.90 | $1.93 | $1.94 | 6 |
| 2028-06-30 | $1.92 | $1.95 | $1.97 | 6 |
| 2028-09-30 | $2.05 | $2.08 | $2.10 | 7 |
| 2028-12-31 | $2.28 | $2.31 | $2.33 | 9 |
| 2029-12-31 | $9.69 | $9.93 | $10.24 | 1 |
| 2030-12-31 | $11.53 | $11.81 | $12.18 | 1 |
Frequently Asked Questions
What is the analyst consensus for AKAM?
The consensus among 23 analysts covering Akamai Technologies, Inc. (AKAM) is Hold with an average price target of $111.18.
What is the highest price target for AKAM?
The highest price target for AKAM is $168.00, set by Ivan Feinseth at Tigress Financial on 2022-01-26.
What is the lowest price target for AKAM?
The lowest price target for AKAM is $75.00, set by Ramond McDonnough at Guggenheim on 2023-02-16.
How many analysts cover AKAM?
23 analysts have issued ratings for Akamai Technologies, Inc. in the past 12 months.
Is AKAM a buy or sell right now?
Based on 23 analyst ratings, AKAM has a consensus rating of Hold (2.52/5) with a +6.8% upside to the consensus target of $111.18.
What are the earnings estimates for AKAM?
Analysts estimate AKAM will report EPS of $6.85 for the period ending 2026-12-31, with revenue estimated at $4.48B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.